05/01/2024
4:21 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:40 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/26/2024
6:30 AM | HCW Biologics (Filer)
| Form DEF 14A | |
04/26/2024
6:30 AM | HCW Biologics (Filer)
| Form ARS | |
04/01/2024
3:31 PM | HCW Biologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
3:15 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:27 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
|
02/22/2024
1:19 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:20 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:21 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:22 PM | Giles Lisa M. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:23 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:24 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:39 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
6:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
3:55 PM | HCW Biologics (Issuer)
Rhode Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
3:44 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:36 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:52 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:53 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
4:33 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
7:40 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
4:25 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:47 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:48 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2023
6:01 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:31 AM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
6:15 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
4:16 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:13 PM | Giles Lisa M. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:14 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:14 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:01 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
6:31 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
7:00 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:49 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
6:24 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:46 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
7:25 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:47 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
06/01/2023
4:29 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
4:33 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:25 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
